DVS Sciences (acquired by Fluidigm/Standard BioTools)
investors.standardbio.com
Innovation Type:
Medical Technologies
Cancer Type:
Multiple
Funding Stage:
Exit
Fund:
Compass Rose
Flow cytometer-mass spectrometer for multi-parametric cell and bead analysis.